1-4 of 4
Ana Villegas, MD, PhD
Close
Sort by
Journal Articles

Treatment of Anemia with Darbepoetin Alfa in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndromes. Results from the ARAMYS Study

Ana Villegas, MD, PhD, B. Arrizabalaga, C. Fernández-lago, M. Mouzo, Jr Mayans, Jr Gonález-Porras, Rafael Duarte, MD, PhD, Angel Francisco Remacha, Elisa Luño, MD, PhD, JA Gasquet
Journal: Blood
Blood (2008) 112 (11): 3451.
https://doi.org/10.1182/blood.V112.11.3451.3451
Published: 2008
Journal Articles

Multiple Site Gfi1b Self-Regulation and GATA1/SCL Pentameric Complex: Shifting the Equilibrium towards Repression

Aurora Hernández, Ana Villegas, MD, PhD, Francisco Iborra, PhD, William G. Wood, PhD, Eduardo Anguita, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4766.
https://doi.org/10.1182/blood.V112.11.4766.4766
Published: 2008
Journal Articles

Immunophenotype in Chronic Myelomonocytic Leukemia: Is It Closer to Myelodysplastic Syndromes or to Myeloproliferative Disorders?.

Dolores Subira, MD, PhD, Patricia Font, MD, Lucia Villalon, MD, Elena Gongora, MD, Cristina Serrano, MD, Mario Rodriguez-Paíno, MD, Elham Askari, MD, Susana Castañon, Tch, Raquel Gonzalo, Tch, Alejandro Roman, MD, Pilar LLamas, MD PhD, Ana Villegas, MD Phd
Journal: Blood
Blood (2007) 110 (11): 4621.
https://doi.org/10.1182/blood.V110.11.4621.4621
Published: 2007
Journal Articles

Gfi1b Association to Human Hematological Abnormalities.

Ana Villegas, MD, PhD, Fernando A. Gonzalez, MD, PhD, Eduardo Anguita, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3748.
https://doi.org/10.1182/blood.V108.11.3748.3748
Published: 2006